Congestive Hepatopathy

Area of Science:

• Cardiology
• Hepatology
• Internal Medicine

Background:

• Heart failure (HF) can lead to liver disease, termed cardiac hepatopathy.
• Congestive hepatopathy (CH), a form of cardiac hepatopathy, arises from chronic right-sided HF and passive venous congestion.
• The etiology of CH has shifted towards ischemic cardiomyopathy and congenital heart disease, differing from historical associations with rheumatic valvular disease.

Purpose of the Study:

• To describe the current spectrum and pathological characteristics of congestive hepatopathy.
• To highlight the progression of liver damage in CH, including fibrosis, cirrhosis, and hepatocellular carcinoma.
• To discuss the implications of improved HF survival on the incidence and clinical relevance of CH.

Main Methods:

• Review of existing literature and clinical data on cardiac hepatopathy and congestive hepatopathy.
• Analysis of pathological changes associated with chronic venous congestion in the liver.
• Evaluation of the diagnostic challenges and prognostic factors in CH.

Main Results:

• Chronic passive congestion in CH leads to sinusoidal hypertension, centrilobular fibrosis, and potentially cardiac cirrhosis and hepatocellular carcinoma.
• Fibrosis in CH exhibits a unique "reversed lobulation" pattern, with inflammation playing a minimal role, unlike in primary liver diseases.
• Non-invasive diagnostic tests for liver fibrosis show poor performance in the context of CH.

Conclusions:

• Advances in HF management have increased patient survival, leading to a rise in liver complications like CH.
• CH can become a significant clinical issue, potentially rivaling the cardiac condition in complexity and management challenges.
• Early recognition and understanding of CH are crucial for managing patients with advanced heart disease.